Study design considerations to assess the impact of potential drug-drug interactions in first-in-human studies in oncology drug development

Clin Transl Sci. 2023 May;16(5):719-722. doi: 10.1111/cts.13496. Epub 2023 Feb 23.
No abstract available

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Drug Development
  • Drug Interactions
  • Humans
  • Medical Oncology
  • Neoplasms* / drug therapy
  • Research Design

Substances

  • Antineoplastic Agents